March 2010
|
-
Switch from protease inhibitor- to efavirenz-based antiretroviral therapy
improves
quality of life, treatment satisfaction and adherence with low rates of
virological
failure in virologically suppressed patients.
Campo RE, Cohen C, Grimm K,
et al Int J STD AIDS.
2010 Mar;21(3):166-71.
-
Impact of Ritonavir, Atazanavir and their Combination on the CYP3A4 Induction
Potential
of Efavirenz in Primary Human Hepatocytes.
Mugundu GM, Hariparsad N, Desai PB.
Drug Metab Lett.
2010 Mar 4.
-
A WEEK-IN REVIEW FEATURED REPORT
The Impact of Once-Nightly Versus Twice-Daily Dosing and
Baseline Beliefs About
HAART on Adherence to Efavirenz-Based HAART Over 48 Weeks:
The NOCTE Study.
Cooper V, Horne R, Gellaitry G, et alJ Acquir Immune Defic Syndr. 2010 Mar
1;53(3):369-77.
|
February 2010
17th CROI Citations
|
-
POSTER
2-Year Evolution of Triglycerides and
Cholesterol in Thai HIV-1-infected Children Receiving
First-line NVP or Efavirenz EFV-based Regimen
S Kanjanavanit, R Hansudewechakul, S Kim,
et al
PDF Poster
Abstract
-
POSTER
A One-pill, Once-daily Fixed-dose Combination of Efavirenz,
Emtricitabine, and
Tenofovir Disoproxil Fumarate Regimen Is Associated with Higher Unannounced
Pill Count Adherence than Non-one-pill, Once-daily Regimens
D Bangsbe, K Ragland, A
Monk, et al
1
PDF Poster
Abstract
-
POSTER
Genotypic Resistance at Viral Rebound in Antiretroviral-Naive Subjects
Randomized to
Receive Lopinavir/Ritonavir (LPV/r) or Efavirenz (EFV)-Based Regimens in South
Africa -
A Substudy of the Phidisa II Trial
J Dlamini, Z H, L Morris,
et al
PDF Poster
Abstract
-
POSTER
Metabolic Profiles and Body Composition Changes in Treatment-Naive HIV-Infected
Patients
Treated with Raltegravir 400 mg Twice-daily vs Efavirenz 600 mg Each bedtime
Combination
Therapy: 96-Week Follow-Up
E DeJesus, C Cohe, J Lennox,
et al
PDF
Poster
Abstract
-
POSTER
Pharmacokinetic Interactions between the Hormonal Emergency Contraception,
Levonorgestrel,
and Efavirenz
M Carten, J Kiser, A Kwara,
et al
PDF Poster
Abstract
-
POSTER
Pharmacokinetics of Efavirenz Dosed According to the WHO Weight-bands in
Children in Uganda
S Bakeera-Kitaka, E
Natukunda, L Kendall, et al
PDF Poster
Abstract
-
Pregnancy,
Efavirenz, and Birth Outcomes in Johannesburg
D Westreich, D Rubel, P
MacDonald, et al
|
Journal Citations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New and Noteworthy
Atripla
ARV
Drugs Main Page
ARV
Drugs Main Page
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader